0000950170-23-034397.txt : 20230725
0000950170-23-034397.hdr.sgml : 20230725
20230725160130
ACCESSION NUMBER: 0000950170-23-034397
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230724
FILED AS OF DATE: 20230725
DATE AS OF CHANGE: 20230725
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morningside Venture Investments Ltd
CENTRAL INDEX KEY: 0001543112
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39894
FILM NUMBER: 231108536
BUSINESS ADDRESS:
STREET 1: MCCARTHY LEGAL SERVICES
STREET 2: 1188 CENTRE STREET
CITY: NEWTON CENTRE
STATE: MA
ZIP: 02459
BUSINESS PHONE: 617-244-2800
MAIL ADDRESS:
STREET 1: MCCARTHY LEGAL SERVICES
STREET 2: 1188 CENTRE STREET
CITY: NEWTON CENTRE
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GreenLight Biosciences Holdings, PBC
CENTRAL INDEX KEY: 0001822691
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851914700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: (617) 616-8188
MAIL ADDRESS:
STREET 1: 29 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: Environmental Impact Acquisition Corp
DATE OF NAME CHANGE: 20200826
4
1
ownership.xml
4
X0508
4
2023-07-24
0001822691
GreenLight Biosciences Holdings, PBC
GRNA
0001543112
Morningside Venture Investments Ltd
2ND FLOOR, LE PRINCE DE GALLES
3-5 AVENUE DES CITRONNIERS
MONACO
O9
MC 98000
MONACO
false
false
true
false
false
Common Stock
2023-07-24
4
J
false
16919155
D
0
D
Consists of 15,919,155 shares of common stock held directly by Morningside Venture Investments Limited and 1,000,000 shares of common stock held by MVIL, LLC, its wholly owned subsidiary.
In connection with the merger of the Issuer with a wholly owned subsidiary of SW ParentCo, Inc. ("Parent"), the Reporting Persons entered into a Contribution and Exchange Agreement pursuant to which, on July 21, 2023, they contributed all of their shares of the Issuer's common stock to Parent in exchange for shares of preferred stock of Parent.
/s/Frances Anne Elizabeth Richard, Director
2023-07-25